ACHC News & Analysis
3 articles
Market Mood
Acadia Healthcare (ACHC) Price Target Raised to $31 After Q1 Beat
Acadia Healthcare Company, Inc. (ACHC) received an upgraded price target from RBC Capital, increasing from $28 to $31 following its fiscal Q1 earnings beat. The firm maintained an Outperform rating on the stock. Similarly, Raymond James upgraded ACHC to Strong Buy, raising its price target from $25 to $39. The analysts noted an increased EBITDA and earnings outlook for 2026 and highlighted the company's strategy to achieve a $200 million target from underperforming facilities. This positive sentiment could potentially lead to an upward movement in ACHC's stock price in the near term.
Read More
Acadia Healthcare (ACHC) Shares Trade at $28.26 with P/E Ratios
Acadia Healthcare Company, Inc. (ACHC) shares were trading at $28.26 as of April 29. The company's trailing P/E ratio stands at 19.82, while the forward P/E is at 19.01. ACHC is experiencing a deteriorating credit profile and has faced rising operational setbacks and legal liabilities, including a ~$400 million legal settlement. With leverage ratios increasing from 1.9x to over 3.4x and reimbursement pressures intensifying, the forecast indicates potential challenges for earnings and cash flow through 2026.
Read More
Acadia (ACHC) Reports Q3 2025 Earnings Results and Forecast
Acadia (ACHC) announced its Q3 2025 earnings, reporting a revenue of $200 million, a 10% increase compared to Q3 2024. The company highlighted a net income of $30 million, reflecting a 15% growth year-over-year. Acadia attributed its success to the expansion of its mental health services and an increase in patient volume. These results are expected to have a positive impact on investor sentiment and market performance for ACHC in upcoming quarters.
Read More